The cannabis market has begun to garner worldwide attention as more countries move to adopt cannabis legislation. Primarily, most countries are looking to adopt medical cannabis laws. Countries that have adopted medical legislation are leveraging cannabis to treat certain medical applications such as cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s disease. Throughout the past year, the cannabis industry has made significant milestones as the U.S. Food and Drug Administration approved its first cannabis-derived drug to treat epilepsy in children. Shortly after, the U.S. Drug Enforcement Agency removed CBD, or cannabidiol, off the Schedule 1 list. CBD-based products that have less than 0.1% THC concentrate will now be considered a Schedule 5 drug, as long as the medication has been approved by the FDA. Furthermore, the FDA recently scheduled a public hearing to be held in May as the agency looks to legalize CBD in food and drinks. The combination of these events has led to the exponential growth of the overall cannabis market. Moreover, as legalization efforts continue, other countries are expected to be influenced and potentially follow in legalizing cannabis. According to data compiled by Grand View Research, the global legal marijuana market was valued at USD 9.3 Billion and is expected to reach USD 146.4 Billion by the end of 2025. Additionally, the market is projected to register a CAGR of 34.6%. CLS Holdings, USA Inc. (OTC: CLSH) (CSE: CLSH.U), Charlotte’s Web Holdings, Inc. (OTC: CWBHF) (CSE: CWEB), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT)
Research and studies conducted within the cannabis industry have helped in adding credibility to the plant. However, the FDA ruled that due to the lack of large-scale and efficient clinical trials, the agency cannot approve cannabis as a registered treatment, yet. Now, researchers and companies involved within the industry are expanding their studies to help expand the cannabis market further. The FDA’s concern over cannabis becoming a legitimate medicine alternative signals the steps the market has taken. Decades ago, cannabis was internationally illegal. Now, countries including Australia, Canada, Columbia, Germany, the Netherlands, Spain, and the U.S. have all adopted cannabis legislation of some form. Moving forward, as more governments and regulatory agencies focus on the topic of cannabis legalization, the cannabis industry can become the next emerging global market. “It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” outgoing FDA Commissioner Scott Gottlieb recently said in a statement.
CLS Holdings, USA Inc. (OTCQB: CLSH) (CSE: CLSH.U) is also listed on the Canadian Securities Exchange under the ticker (CSE: CLSH.U). Earlier last week, the Company announced that, “since acquiring Oasis Cannabis Dispensary in Las Vegas, Nevada, CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH.U) has been working to elevate the entire customer experience behind cannabis. The catchphrase “New Oasis, Same Faces” assures customers that they will still receive the same care and attention they’ve come to expect from Oasis Cannabis, only now in a totally redesigned, modern, and fresh facility. The new space is more accessible, inviting and vibrant, with the same friendly and knowledgeable staff. Over the past few months, walls have been torn down and the color scheme have been modernized from lime green to bright white with blue accents, evoking a vibrant and calming feel. LED lit display cases are purposefully and openly situated, allowing customers ample room to explore products. The large white bud bar hosts the budtender, who is able to curate a better user experience through education and a diverse product selection. At the heart of the renovation is improving customer experience – but the company’s dedication to education, compassionate care, and community enrichment remain the same.
All are welcome to join the Oasis Cannabis Grand Reopening Party, which will take place at the dispensary on Saturday April 6th 2019 from 12:00pm – 10:00pm. The event will feature vendors on-site, live art, live music, food trucks, and special prices. The dispensary is located at 1800 Industrial Rd #180, Las Vegas, NV 89102.
About Oasis Cannabis: Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine.
In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com
About City Trees: Founded in 2017, City Trees is a Nevada based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 40 dispensaries. https://citytrees.com
About CLS Holdings USA, Inc: CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.”
For our latest “Buzz on the Street” Show featuring CLS Holdings, USA Inc. recent corporate news, please head over to:
Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB) is the market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Recently, Charlotte’s Web Holdings, Inc. surpassed 3,000 retail locations across the United States. At the end of 2017, Charlotte’s Web products were sold in approximately 2,000 locations. The Company had recently that it surpassed its 2018 year-end goal of 3,000 locations during the 3rd quarter. With CBD gaining mainstream market momentum, Charlotte’s Web, the industry pioneer and category leader in hemp-based CBD, has expanded its suite of product offerings across a wider variety of retailers, from small specialty health food stores to now including regional pharmacy and grocery chains. “Firstly, I would like to commend our incredible and committed staff who worked tirelessly to achieve this milestone,” stated Charlotte’s Web Chief Executive Officer Hess Moallem. “I would also like to thank our dedicated retail partners for their continued support of our mission and for valuing the trust that is closely associated with our brand name.”
Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) recently announced that they have entered into a definitive agreement, pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House. Under the terms of the Agreement, holders of common shares of Origin House will receive 0.8428 subordinate voting shares of Cresco Labs for each Origin House Share. Origin House has become a leading distributor and provider of brand support services in California, the world’s largest regulated cannabis market. Origin House’s proven strategy has been to build relationships with established dispensaries, build partnerships with established market-leading brands, develop promising cannabis product companies, and then leverage its full suite of support services to transform those products into strong California consumer brands. Origin House delivers over 50+ cannabis brands to more than 500 dispensaries in California, representing approximately 60% market penetration. “The acquisition of Origin House is another example of our focused and disciplined approach to creating a meaningful presence in key cannabis markets through excellence in brand development and distribution,” said Cresco Labs Chief Executive Officer and Co-founder Charlie Bachtell.
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals, Inc. recently announced that it has initiated the Phase 2 BRIGHT (An Open-Label Tolerability and Efficacy Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Autism Spectrum Disorder) trial. The trial will assess the safety, tolerability and efficacy of Zygel (previously referred to as ZYN002) for the treatment of child and adolescent patients with Autism Spectrum Disorder (ASD). The Company expects to present topline data from this study in the first half of 2020. Clinical and anecdotal data suggest that CBD may modulate the EC system and improve certain core social and behavioral autism-related symptoms, including social avoidance and anxiety. “Autism spectrum disorder can have a devastating impact on a child and their family,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “The medical need is significant and unmet despite high awareness and advocacy efforts. Though there has been an accelerating rate of diagnosis, to date there are only two FDA approved products indicated for the treatment of ASD symptoms.”
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) specializes in the extraction, purification and formulation of health and wellness products. Neptune Wellness Solutions Inc. recently announced that it had completed its initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec. “The quality of the extracts in Neptune’s first production runs at our state-of-the-art facility has been terrific, and we are proud to begin deliveries. This marks an important step forward in the execution of our vision to lever our decades of extraction and wellness industry experience towards becoming the world’s leader in the extraction, purification and formulation of value-added, differentiated cannabis products,” said Jim Hamilton, President and Chief Executive Officer of Neptune.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
Personalized Learning Paths Offer Roadmaps to Dream Jobs
When moving into a new career or field, determining how your strengths transfer and what additional skills you need to learn can be challenging; Forbes SmartAdvisor bridges this gap.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8716951-forbes-smartadvisor-personalized-learning-paths-offer-roadmaps-to-dream-jobs/
By utilizing three information points—users’ personality, their current skills, and the skills necessary for the aspirational role they selected—Forbes SmartAdvisor creates a customized learning path. This Learning Path is personalized just for you. It identifies which self-paced course from Learn@Forbes’ library of over 700 courses, specializations, and Learning Pathways in marketing, human resources, leadership, finance and accounting, entrepreneurship, sales, communications, customer service, and project management make sense for the career you’re aspiring to.
How It Works
Forbes SmartAdvisor, which is free, and takes just three minutes to complete. First, you will complete a brief personality assessment. Second, you select the aspirational role you want, and third, you upload your resume (which is optional).
Using Holland’s Occupational Model and Gardner’s Theory of Multiple Intelligence model, in moments, you will receive your personalized and unbiased results. Insights on your learning style(s), working style(s), attributes, and skills are provided in your custom report, as is a learning pathway that maps the Learn@Forbes courses that will teach you the additional skills you need to get the job you want. Each course on your personalized learning path is self-paced. And, you can take as many as you would like at a time.
Forbes SmartAdvisor users can save their results for future reference. Those who would like to start their personalized learning path can do so with a free 14-day trial. Learn@Forbes subscriptions start at $12.50 per month. For additional information, visit learn.forbes.com.
MRA Group Develops Lab Spaces to Keep Up with Cell and Gene Therapy Demand in Philadelphia Region
In response to the growing cell and gene therapy demand in the Philadelphia region, MRA Group (MRA) is pressing onward to deliver by year end, two specialized multi-tenant life science lab buildings: a 65,000+/-SF lab building in the city of Philadelphia and a 72,000+/-SF lab building at Spring House Innovation Park, just outside the city.
“Through this pandemic, we continue to see strong demand from growing in-market life science prospects and out-of-market entrants looking for high-quality lab space,” said Phil Butler, Vice President of MRA Group. “Prospective tenants value speed-to-market, and given the regional demand, we believe pushing forward is the right thing to do.”
While construction slowed due to COVID-19 mandated shutdowns, MRA remains on track to welcome tenants this year to newly developed, state-of-the-art, customizable, hard-to-come-by lab space in the region. Now that Philadelphia is a nationally recognized biomedical cluster, or a Big4Bio region, prospective life science companies attracted to the area have encountered a shortage of available lab space; a concern MRA Group is working to correct.
“A recent study found 98% of commercial lab space is occupied,” said Sam Woods Thomas, Director of Life Sciences and Biotechnology for the City of Philadelphia. “We are excited by and proud of MRA Group’s efforts to broaden our Life Sciences real estate pipeline. Philadelphia scientists and academic institutions are pioneers in innovation, but they need more space to continue,” Thomas shared. “MRA Group’s development efforts are essential pieces to this sector’s continued growth in our city and region.”
Spring House Innovation Park’s new 72,000+/-SF rentable lab building is within the BioLaunch611+ Keystone Innovation Zone and sits on the sprawling, 133-acre, Lower Gwynedd, Montgomery County campus owned and developed by MRA Group.
“When we acquired Spring House Innovation Park in 2017, we sought to create a suburban life science destination,” said Mike Wojewodka, Senior Vice President of MRA Group. “To date, we have approximately 150,000 square feet leased to nearly two dozen tenants, of which nearly half are in the life science industry. We’ve recently welcomed AnPac Bio, a leading international biotechnology company, while later this summer a gene therapy company, Exegenesis Bio, will be joining our roster which includes Jefferson Institute for Bioprocessing. Based on current leasing activity, we anticipate the 72,000+/-SF lab building being fully leased and occupied by the end of the year, which is why MRA remains focused and bullish on developing these much needed lab spaces for our region.” Companies interested in Spring House Innovation Park, visit www.springhouseinnovationpark.net.
Additionally, MRA Group, on behalf of a local university, is developing a 65,000+/-SF scientifically advanced, multi-tenant wet and dry lab and office building in Philadelphia.
Auto Theft Recoveries Soar During COVID-19 Lockdown
LoJack®, a brand of CalAmp (Nasdaq: CAMP) and a leader in stolen vehicle recovery (SVR) and innovative automotive services, today announced auto theft recoveries in the U.S. jumped 15 percent in April 2020 over April 2019 and continued to grow in May, outpacing last year’s number at this time by 11 percent. The report indicates an increase in auto theft recoveries, and highlights changes from the same period last year to date, demonstrating that while auto theft is on the rise during the COVID-19 lockdown, consumers must stay vigilant and protect their vehicles.
While essential workers travel to and from work and others have sheltered in place, auto thieves continue to operate during a global pandemic according to LoJack’s U.S. Recoveries Trends report. The report found that the U.S. — during the rising spread of COVID-19 — saw a big increase in stolen vehicle recovery across the country in April 2020 compared with April 2019. In May, the following states saw a significant increase in auto theft recoveries:
- California increased 35 percent
- Colorado increased 20 percent
- Washington State increased 25 percent
With the Fourth of July holiday approaching, LoJack and CalAmp urge drivers to take these simple precautions:
- Try to park your car in well-lit areas or within range of security cameras
- Don’t leave valuables in plain sight in your vehicle
- Double check to make sure your vehicle is locked
- Don’t leave windows or sunroofs cracked and don’t leave your car running unattended
- Be mindful of where you leave your keys or key fob; don’t leave a spare key in the vehicle
“It’s clear that auto thieves have been hard at work during the pandemic,” said Justin Schmid, senior vice president, general manager of LoJack Global. “The cost of losing a vehicle to theft during a time like this where many people have lost their jobs and income builds on already elevated stress levels and an experience that no one wants to face. It’s important to LoJack and CalAmp that we share the facts and equip Americans with solutions that protect their families and bring peace of mind during an already chaotic time.”
Stories across the U.S., including a nurse in Boston who had her car stolen in April from her driveway while between shifts at the local hospital, remind us that no one is immune. With COVID-19 continuing to impact communities, auto theft should be the least of one’s worries, including frontline workers. Between their telematics-based connected car app SureDrive™ and the traditional LoJack® System technology, LoJack offers a variety of solutions to protect vehicles and provide additional support for drivers, with features including:
- Stolen Vehicle Location Assist: Provides trained U.S.-based agents to coordinate directly with law enforcement to help track and locate a stolen vehicle.
- CrashBoxx™: Sends instant crash alerts to loved ones with trained U.S.-based agents available to help provide timely assistance and facilitate emergency response
- Tripwire™ Early Warning: Enables proactive monitoring and alerts consumers of unexpected car movement, such as when towed or stolen.
- Virtual Boundaries: Allows consumers to set easily configurable boundaries that send notifications when loved ones arrive at their destination.
- Destination Search: Displays integrated and searchable landmarks such as emergency rooms, gas stations, car washes, or other key destinations.
- Where’s My Car: Delivers real-time location of your vehicle, whether driving or parked.
- Speed Alerts: Enables parents to set a speed threshold and receive alerts if a teen driver or other loved one goes faster than they should
The LoJack Stolen Vehicle Recovery System consistently delivers a 90% plus recovery rate on cars, trucks, and SUVs, and over $1 billion worth of LoJack-equipped vehicles have been recovered in the U.S. alone*.
“We are committed to supporting families with innovative solutions that protect their vehicles and loved ones, consistent with the proven LoJack brand promise of safety and security for the road ahead,” said Schmid.
*LoJack® unit activation is contingent upon the vehicle being located within LoJack’s SVRU coverage area that spans counties across 29 states throughout the U.S. and the District of Columbia. You may find LoJack’s coverage areas at www.lojack.com/coverage or by calling 1-800-4-LoJack. Used car values are best estimates derived from NADA Guide web services values and clean retail value from NADAGuides.com for the make, model and year of the vehicle in the month it was recovered.
Latest News1 year ago
Bleckwen Raises $10m and Appoints David Christie as CEO
Artificial Intelligence1 year ago
Kneron Debuts Edge AI Chip, Bringing AI to Devices Everywhere
Artificial Intelligence1 year ago
Chartis Research Names FICO a Category Leader in AI for Financial Services
Artificial Intelligence1 year ago
CredoLab extends smartphone-based scoring to insurers
Artificial Intelligence1 year ago
LogRhythm Scores the Singapore Business Review Technology Excellence Award 2019 for Cyber Security – Computer Software
Artificial Intelligence1 year ago
Tuya Exhibiting Products from its Global Clients that are “Powered by Tuya”
Artificial Intelligence1 year ago
Chengdu Tianfu Software Park Reflects the Vitality of IP Innovation
Artificial Intelligence3 months ago
Special Report: Coronavirus and the Housing Industry